- Report
- August 2025
- 224 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 129 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- July 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- April 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- April 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- March 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- March 2025
- 250 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- January 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- January 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- March 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- March 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- August 2025
- 488 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 475 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 364 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 373 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 291 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 286 Pages
Global
From €5193EUR$5,850USD£4,469GBP
- Report
- August 2025
- 284 Pages
Global
From €5193EUR$5,850USD£4,469GBP

Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies.
Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more